Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Gadde
Krupa Benhur Gadde, Andhra Pradesh IN
| Patent application number | Description | Published |
|---|---|---|
| 20120078913 | SYSTEM AND METHOD FOR SCHEMA MATCHING - A system and method for matching one or more source schemas with one or more target schemas is provided. The matching between source and target schemas is performed by gathering inputs pertaining to the source and target schemas, wherein the inputs comprises a set of details in a predefined format. Thereafter, the gathered inputs are processed by comparing the source schemas with the target schemas. The processing is performed to identify a set of matches between the source and target schemas based on the linguistic similarity, structural similarity and functional similarity and relationship between the source and target schemas. Subsequently, the identified matches are stored. | 03-29-2012 |
Prasad Gadde, Hyderabad IN
| Patent application number | Description | Published |
|---|---|---|
| 20120059918 | LOCATION BASED SERVICE DATA CONNECTION SUPPORT ACROSS MULTIPLE PROFILES - In a wireless data packet network, a single mobile device is provisioned to support a plurality of user profiles including a service or application that can be associated to multiple profiles. Arbitration for requests for a data connection can be made based upon priority, with applications having the same priority allowed to share the data connection. In some instances, the profile used to establish the data connection does not support the application that can be associated to multiple profiles, such as Location Based Services (LBS). To minimize subsequent rejections of requests for a data connection by the LBS, capability scans or updates determine what services are supported by the currently active profiles. | 03-08-2012 |
Ramachandraiah Gadde, Bhavnagar IN
| Patent application number | Description | Published |
|---|---|---|
| 20090188810 | Process for the Preparation of Stable Iodate-Exchanged Synthetic Hydrotalcite with Zero Effluent Discharge - The present invention relates to a process for the preparation of stable iodate-exchanged hydrotalcite with zero effluent discharge. The iodate-exchanged hydrotalcite produced is useful as iodizing agent. The invention further relates to utilization of alkaline effluent generated in the process of ion exchange of iodate into SHT so as to fully recycle the residual iodate anion and also utilize the alkali generated in the process for production of additional quantities of iodate through reaction with iodine crystals followed by electrochemical oxidation to obtain pure aqueous solution of iodate salt which can be reused for preparation of the stable iodizing agent. The process gives zero effluent discharge hence economical. | 07-30-2009 |
Sathyanarayana Gadde, Tamilnadu IN
| Patent application number | Description | Published |
|---|---|---|
| 20100329998 | NOVEL HETEROCYCLES - Described are novel heterocyclic compounds of the general formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof. These compounds are useful in the treatment of immunological diseases, inflammation, pain disorder, rheumatoid arthritis; osteoporosis; multiple myeloma; uveititis; acute and chronic myelogenous leukemia; atherosclerosis; cancer; cachexia; ischemic-induced cell damage; pancreatic beta cell destruction; osteoarthritis; rheumatoid spondylitis; gouty arthritis; inflammatory bowel disease; ARDS; psoriasis; Crohn's disease; allergic rhinitis; ulcerative colitis; anaphylaxis; contact dermatitis; muscle degeneration; asthma; COPD; bone resorption diseases; multiple sclerosis; sepsis; septic shock; toxic shock syndrome and fever. More particularly these compounds are useful as PDE4 inhibitors and are useful for treating PDE4 mediated diseases. | 12-30-2010 |
Sathyanarayana Gadde, Chennai IN
| Patent application number | Description | Published |
|---|---|---|
| 20080207606 | Novel heterocycles - Novel heterocyclic compounds of the general formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof are described. These compounds are useful in the treatment of immunological diseases, inflammation, pain disorder, rheumatoid arthritis; osteoporosis; multiple myeloma; uveititis; acute and chronic myelogenous leukemia; atherosclerosis; cancer; cachexia; ischemic-induced cell-damage; pancreatic beta cell destruction; osteoarthritis; rheumatoid spondylitis; gouty arthritis; inflammatory bowel disease; adult respiratory distress syndrome (ARDS); psoriasis; Crohn's disease; allergic rhinitis; ulcerative colitis; anaphylaxis; contact dermatitis; muscle degeneration; asthma; COPD; bone resorption diseases; multiple sclerosis; sepsis; septic shock; toxic shock syndrome and fever. More particularly these compounds are useful as PDE4 inhibitors, and useful for treating PDE4 mediated diseases. | 08-28-2008 |